EXECUTIVE ENGAGEMENTS
POOL
7311
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
1024
Interactions with Platform & by Email
PARTICIPANTS
219
Unique # Participated
VALIDATIONS
78
Responses Validated*
COMPANIES
92
Responses Validated*
* Login for a full stack data experience
DATE
APR 2021
TABLES
297
PAGES
419
EDITION
16
PRICE
USD 5600
CODE
MCP-2528
*Engagement stats are ongoing and dynamic
HIGHLIGHTS & REPORT INDEX
Global Contraceptives Market to Reach $28 Billion by 2026
Amid the COVID-19 crisis, the global market for Contraceptives estimated at US$21.7 Billion in the year 2020, is projected to reach a revised size of US$28 Billion by 2026, growing at a CAGR of 4.3% over the analysis period. Drugs, one of the segments analyzed in the report, is projected to record a 4.6% CAGR and reach US$18.8 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Devices segment is readjusted to a revised 3.7% CAGR for the next 7-year period.
The U.S. Market is Estimated at $6 Billion in 2021, While China is Forecast to Reach $5.9 Billion by 2026
The Contraceptives market in the U.S. is estimated at US$6 Billion in the year 2021. China, the world`s second largest economy, is forecast to reach a projected market size of US$5.9 Billion by the year 2026 trailing a CAGR of 7.7% over the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 1.4% and 3.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.2% CAGR.
SELECT PLAYERS
Agile Therapeutics, Inc.; Allergan plc; Ansell Limited; Bayer AG; Church & Dwight Co., Inc.; CooperSurgical Inc.; Fuji Latex Co. Ltd.; Janssen Pharmaceuticals, Inc.; Karex Berhad; Mankind Pharma Ltd.; Okamoto Industries, Inc.; Pfizer Inc.; Piramal Enterprises Ltd.; Reckitt Benckiser Group Plc.; Sagami Rubber Industries Co., Ltd.; Teva Pharmaceutical Industries Ltd.; Thai Nippon Rubber Industry Co., Ltd.
SEGMENTS
» Product Type (Drugs, Devices) » Gender (Female, Male) » End-Use (Household, Hospitals, Clinics)
GEOGRAPHIES
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » Spain » Russia » and Rest of Europe » Asia-Pacific » Australia » India » South Korea » and Rest of Asia-Pacific » Latin America » Argentina » Brazil » Mexico » and Rest of Latin America » Middle East » Iran » Israel » Saudi Arabia » United Arab Emirates » and Rest of Middle East » and Africa
TABLE OF CONTENTS
| I. METHODOLOGY |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Influencer Market Insights |
| World Market Trajectories |
| Impact of Covid-19 and a Looming Global Recession |
| Contraceptives: Transforming Birth Control, Planned Parenthood, and Women’s Health |
| Contraceptives Market: Fast Facts |
| The Vital Need to Curtail the Ballooning Global Population through Birth Control: |
| Effectiveness Index of Contraceptive Methods: Brief Details of Method, Efficacy Percentage, Benefits, Risks, and Availability |
| Unmet Contraception Needs Signals Huge Market Penetration Opportunities |
| Global Population Statistics: Unfurling the Market Potential |
| China & India: Two Countries with the Largest Sexually Active Population Offer Significant Growth Opportunities |
| Global Market Outlook |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| Condoms as a Powerful Tool against HIV/AIDS and Other STIs Witness Strong Growth in Demand |
| Condoms: Percentage Effectiveness of Protection against STDs |
| Contraceptive Innovations and Advancements: Spearheading Growth |
| Major Condom Innovations |
| Declining Prices and Increased Accessibility of Contraceptives Benefit Market Expansion |
| Despite Waning Popularity, Oral Contraceptives Continue to Sustain Market Domination |
| Rising Need to Develop Contraceptives for Men Drive Robust Research & Development |
| Evolving Designs and Features in Female Condoms Drive Surging Popularity and Growing Adoption |
| Increasing Standard of Living: A Key Growth Driver |
| Social Stigmas in Under Developed Countries Hamper Market Prospects |
| Major Hindrances for Widespread Usages of Condoms |
| Developing Countries Continue to Drive Current and Future Market Growth |
| Manufacturers Depend on Emerging Markets to Increase Sales Momentum |
| 4. GLOBAL MARKET PERSPECTIVE |
| World Current & Future Analysis for Contraceptives by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Contraceptives by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Contraceptives by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Female by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Female by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Female by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Male by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Male by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Male by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Household by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Household by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Household by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| III. MARKET ANALYSIS |
| UNITED STATES |
| USA Current & Future Analysis for Contraceptives by Product Type - Drugs and Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Contraceptives by Product Type - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Contraceptives by Product Type - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2012, 2020 & 2027 |
| USA Current & Future Analysis for Contraceptives by Gender - Female and Male - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Contraceptives by Gender - Female and Male Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female and Male for the Years 2012, 2020 & 2027 |
| USA Current & Future Analysis for Contraceptives by End-Use - Household, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Contraceptives by End-Use - Household, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Contraceptives by End-Use - Percentage Breakdown of Value Sales for Household, Hospitals and Clinics for the Years 2012, 2020 & 2027 |
| CANADA |
| Canada Current & Future Analysis for Contraceptives by Product Type - Drugs and Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Contraceptives by Product Type - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Contraceptives by Product Type - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2012, 2020 & 2027 |
| Canada Current & Future Analysis for Contraceptives by Gender - Female and Male - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Contraceptives by Gender - Female and Male Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female and Male for the Years 2012, 2020 & 2027 |
| Canada Current & Future Analysis for Contraceptives by End-Use - Household, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Contraceptives by End-Use - Household, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Contraceptives by End-Use - Percentage Breakdown of Value Sales for Household, Hospitals and Clinics for the Years 2012, 2020 & 2027 |
| JAPAN |
| Japan Current & Future Analysis for Contraceptives by Product Type - Drugs and Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Contraceptives by Product Type - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Contraceptives by Product Type - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2012, 2020 & 2027 |
| Japan Current & Future Analysis for Contraceptives by Gender - Female and Male - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Contraceptives by Gender - Female and Male Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female and Male for the Years 2012, 2020 & 2027 |
| Japan Current & Future Analysis for Contraceptives by End-Use - Household, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Contraceptives by End-Use - Household, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Contraceptives by End-Use - Percentage Breakdown of Value Sales for Household, Hospitals and Clinics for the Years 2012, 2020 & 2027 |
| CHINA |
| China Current & Future Analysis for Contraceptives by Product Type - Drugs and Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Contraceptives by Product Type - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Contraceptives by Product Type - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2012, 2020 & 2027 |
| China Current & Future Analysis for Contraceptives by Gender - Female and Male - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Contraceptives by Gender - Female and Male Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female and Male for the Years 2012, 2020 & 2027 |
| China Current & Future Analysis for Contraceptives by End-Use - Household, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Contraceptives by End-Use - Household, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Contraceptives by End-Use - Percentage Breakdown of Value Sales for Household, Hospitals and Clinics for the Years 2012, 2020 & 2027 |
| EUROPE |
| Europe Current & Future Analysis for Contraceptives by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Contraceptives by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Contraceptives by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for Contraceptives by Product Type - Drugs and Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Contraceptives by Product Type - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Contraceptives by Product Type - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for Contraceptives by Gender - Female and Male - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Contraceptives by Gender - Female and Male Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female and Male for the Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for Contraceptives by End-Use - Household, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Contraceptives by End-Use - Household, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Contraceptives by End-Use - Percentage Breakdown of Value Sales for Household, Hospitals and Clinics for the Years 2012, 2020 & 2027 |
| FRANCE |
| France Current & Future Analysis for Contraceptives by Product Type - Drugs and Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Contraceptives by Product Type - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Contraceptives by Product Type - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2012, 2020 & 2027 |
| France Current & Future Analysis for Contraceptives by Gender - Female and Male - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Contraceptives by Gender - Female and Male Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female and Male for the Years 2012, 2020 & 2027 |
| France Current & Future Analysis for Contraceptives by End-Use - Household, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Contraceptives by End-Use - Household, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Contraceptives by End-Use - Percentage Breakdown of Value Sales for Household, Hospitals and Clinics for the Years 2012, 2020 & 2027 |
| GERMANY |
| Germany Current & Future Analysis for Contraceptives by Product Type - Drugs and Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Contraceptives by Product Type - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Contraceptives by Product Type - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2012, 2020 & 2027 |
| Germany Current & Future Analysis for Contraceptives by Gender - Female and Male - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Contraceptives by Gender - Female and Male Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female and Male for the Years 2012, 2020 & 2027 |
| Germany Current & Future Analysis for Contraceptives by End-Use - Household, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Contraceptives by End-Use - Household, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Contraceptives by End-Use - Percentage Breakdown of Value Sales for Household, Hospitals and Clinics for the Years 2012, 2020 & 2027 |
| ITALY |
| Italy Current & Future Analysis for Contraceptives by Product Type - Drugs and Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Contraceptives by Product Type - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Contraceptives by Product Type - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2012, 2020 & 2027 |
| Italy Current & Future Analysis for Contraceptives by Gender - Female and Male - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Contraceptives by Gender - Female and Male Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female and Male for the Years 2012, 2020 & 2027 |
| Italy Current & Future Analysis for Contraceptives by End-Use - Household, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Contraceptives by End-Use - Household, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Contraceptives by End-Use - Percentage Breakdown of Value Sales for Household, Hospitals and Clinics for the Years 2012, 2020 & 2027 |
| UNITED KINGDOM |
| UK Current & Future Analysis for Contraceptives by Product Type - Drugs and Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Contraceptives by Product Type - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Contraceptives by Product Type - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2012, 2020 & 2027 |
| UK Current & Future Analysis for Contraceptives by Gender - Female and Male - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Contraceptives by Gender - Female and Male Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female and Male for the Years 2012, 2020 & 2027 |
| UK Current & Future Analysis for Contraceptives by End-Use - Household, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Contraceptives by End-Use - Household, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Contraceptives by End-Use - Percentage Breakdown of Value Sales for Household, Hospitals and Clinics for the Years 2012, 2020 & 2027 |
| SPAIN |
| Spain Current & Future Analysis for Contraceptives by Product Type - Drugs and Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Spain Historic Review for Contraceptives by Product Type - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Spain 15-Year Perspective for Contraceptives by Product Type - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2012, 2020 & 2027 |
| Spain Current & Future Analysis for Contraceptives by Gender - Female and Male - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Spain Historic Review for Contraceptives by Gender - Female and Male Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Spain 15-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female and Male for the Years 2012, 2020 & 2027 |
| Spain Current & Future Analysis for Contraceptives by End-Use - Household, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Spain Historic Review for Contraceptives by End-Use - Household, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Spain 15-Year Perspective for Contraceptives by End-Use - Percentage Breakdown of Value Sales for Household, Hospitals and Clinics for the Years 2012, 2020 & 2027 |
| RUSSIA |
| Russia Current & Future Analysis for Contraceptives by Product Type - Drugs and Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Russia Historic Review for Contraceptives by Product Type - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Russia 15-Year Perspective for Contraceptives by Product Type - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2012, 2020 & 2027 |
| Russia Current & Future Analysis for Contraceptives by Gender - Female and Male - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Russia Historic Review for Contraceptives by Gender - Female and Male Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Russia 15-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female and Male for the Years 2012, 2020 & 2027 |
| Russia Current & Future Analysis for Contraceptives by End-Use - Household, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Russia Historic Review for Contraceptives by End-Use - Household, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Russia 15-Year Perspective for Contraceptives by End-Use - Percentage Breakdown of Value Sales for Household, Hospitals and Clinics for the Years 2012, 2020 & 2027 |
| REST OF EUROPE |
| Rest of Europe Current & Future Analysis for Contraceptives by Product Type - Drugs and Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Contraceptives by Product Type - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Contraceptives by Product Type - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2012, 2020 & 2027 |
| Rest of Europe Current & Future Analysis for Contraceptives by Gender - Female and Male - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Contraceptives by Gender - Female and Male Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female and Male for the Years 2012, 2020 & 2027 |
| Rest of Europe Current & Future Analysis for Contraceptives by End-Use - Household, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Contraceptives by End-Use - Household, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Contraceptives by End-Use - Percentage Breakdown of Value Sales for Household, Hospitals and Clinics for the Years 2012, 2020 & 2027 |
| ASIA-PACIFIC |
| Asia-Pacific Current & Future Analysis for Contraceptives by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Contraceptives by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Contraceptives by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2020 & 2027 |
| Asia-Pacific Current & Future Analysis for Contraceptives by Product Type - Drugs and Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Contraceptives by Product Type - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Contraceptives by Product Type - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2012, 2020 & 2027 |
| Asia-Pacific Current & Future Analysis for Contraceptives by Gender - Female and Male - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Contraceptives by Gender - Female and Male Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female and Male for the Years 2012, 2020 & 2027 |
| Asia-Pacific Current & Future Analysis for Contraceptives by End-Use - Household, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Contraceptives by End-Use - Household, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Contraceptives by End-Use - Percentage Breakdown of Value Sales for Household, Hospitals and Clinics for the Years 2012, 2020 & 2027 |
| AUSTRALIA |
| Australia Current & Future Analysis for Contraceptives by Product Type - Drugs and Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Australia Historic Review for Contraceptives by Product Type - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Australia 15-Year Perspective for Contraceptives by Product Type - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2012, 2020 & 2027 |
| Australia Current & Future Analysis for Contraceptives by Gender - Female and Male - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Australia Historic Review for Contraceptives by Gender - Female and Male Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Australia 15-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female and Male for the Years 2012, 2020 & 2027 |
| Australia Current & Future Analysis for Contraceptives by End-Use - Household, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Australia Historic Review for Contraceptives by End-Use - Household, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Australia 15-Year Perspective for Contraceptives by End-Use - Percentage Breakdown of Value Sales for Household, Hospitals and Clinics for the Years 2012, 2020 & 2027 |
| INDIA |
| India Current & Future Analysis for Contraceptives by Product Type - Drugs and Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| India Historic Review for Contraceptives by Product Type - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| India 15-Year Perspective for Contraceptives by Product Type - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2012, 2020 & 2027 |
| India Current & Future Analysis for Contraceptives by Gender - Female and Male - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| India Historic Review for Contraceptives by Gender - Female and Male Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| India 15-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female and Male for the Years 2012, 2020 & 2027 |
| India Current & Future Analysis for Contraceptives by End-Use - Household, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| India Historic Review for Contraceptives by End-Use - Household, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| India 15-Year Perspective for Contraceptives by End-Use - Percentage Breakdown of Value Sales for Household, Hospitals and Clinics for the Years 2012, 2020 & 2027 |
| SOUTH KOREA |
| South Korea Current & Future Analysis for Contraceptives by Product Type - Drugs and Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| South Korea Historic Review for Contraceptives by Product Type - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| South Korea 15-Year Perspective for Contraceptives by Product Type - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2012, 2020 & 2027 |
| South Korea Current & Future Analysis for Contraceptives by Gender - Female and Male - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| South Korea Historic Review for Contraceptives by Gender - Female and Male Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| South Korea 15-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female and Male for the Years 2012, 2020 & 2027 |
| South Korea Current & Future Analysis for Contraceptives by End-Use - Household, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| South Korea Historic Review for Contraceptives by End-Use - Household, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| South Korea 15-Year Perspective for Contraceptives by End-Use - Percentage Breakdown of Value Sales for Household, Hospitals and Clinics for the Years 2012, 2020 & 2027 |
| REST OF ASIA-PACIFIC |
| Rest of Asia-Pacific Current & Future Analysis for Contraceptives by Product Type - Drugs and Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Asia-Pacific Historic Review for Contraceptives by Product Type - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Asia-Pacific 15-Year Perspective for Contraceptives by Product Type - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2012, 2020 & 2027 |
| Rest of Asia-Pacific Current & Future Analysis for Contraceptives by Gender - Female and Male - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Asia-Pacific Historic Review for Contraceptives by Gender - Female and Male Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Asia-Pacific 15-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female and Male for the Years 2012, 2020 & 2027 |
| Rest of Asia-Pacific Current & Future Analysis for Contraceptives by End-Use - Household, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Asia-Pacific Historic Review for Contraceptives by End-Use - Household, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Asia-Pacific 15-Year Perspective for Contraceptives by End-Use - Percentage Breakdown of Value Sales for Household, Hospitals and Clinics for the Years 2012, 2020 & 2027 |
| LATIN AMERICA |
| Latin America Current & Future Analysis for Contraceptives by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| Latin America Historic Review for Contraceptives by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Latin America 15-Year Perspective for Contraceptives by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2020 & 2027 |
| Latin America Current & Future Analysis for Contraceptives by Product Type - Drugs and Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Latin America Historic Review for Contraceptives by Product Type - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Latin America 15-Year Perspective for Contraceptives by Product Type - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2012, 2020 & 2027 |
| Latin America Current & Future Analysis for Contraceptives by Gender - Female and Male - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Latin America Historic Review for Contraceptives by Gender - Female and Male Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Latin America 15-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female and Male for the Years 2012, 2020 & 2027 |
| Latin America Current & Future Analysis for Contraceptives by End-Use - Household, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Latin America Historic Review for Contraceptives by End-Use - Household, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Latin America 15-Year Perspective for Contraceptives by End-Use - Percentage Breakdown of Value Sales for Household, Hospitals and Clinics for the Years 2012, 2020 & 2027 |
| ARGENTINA |
| Argentina Current & Future Analysis for Contraceptives by Product Type - Drugs and Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Argentina Historic Review for Contraceptives by Product Type - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Argentina 15-Year Perspective for Contraceptives by Product Type - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2012, 2020 & 2027 |
| Argentina Current & Future Analysis for Contraceptives by Gender - Female and Male - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Argentina Historic Review for Contraceptives by Gender - Female and Male Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Argentina 15-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female and Male for the Years 2012, 2020 & 2027 |
| Argentina Current & Future Analysis for Contraceptives by End-Use - Household, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Argentina Historic Review for Contraceptives by End-Use - Household, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Argentina 15-Year Perspective for Contraceptives by End-Use - Percentage Breakdown of Value Sales for Household, Hospitals and Clinics for the Years 2012, 2020 & 2027 |
| BRAZIL |
| Brazil Current & Future Analysis for Contraceptives by Product Type - Drugs and Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Brazil Historic Review for Contraceptives by Product Type - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Brazil 15-Year Perspective for Contraceptives by Product Type - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2012, 2020 & 2027 |
| Brazil Current & Future Analysis for Contraceptives by Gender - Female and Male - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Brazil Historic Review for Contraceptives by Gender - Female and Male Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Brazil 15-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female and Male for the Years 2012, 2020 & 2027 |
| Brazil Current & Future Analysis for Contraceptives by End-Use - Household, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Brazil Historic Review for Contraceptives by End-Use - Household, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Brazil 15-Year Perspective for Contraceptives by End-Use - Percentage Breakdown of Value Sales for Household, Hospitals and Clinics for the Years 2012, 2020 & 2027 |
| MEXICO |
| Mexico Current & Future Analysis for Contraceptives by Product Type - Drugs and Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Mexico Historic Review for Contraceptives by Product Type - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Mexico 15-Year Perspective for Contraceptives by Product Type - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2012, 2020 & 2027 |
| Mexico Current & Future Analysis for Contraceptives by Gender - Female and Male - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Mexico Historic Review for Contraceptives by Gender - Female and Male Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Mexico 15-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female and Male for the Years 2012, 2020 & 2027 |
| Mexico Current & Future Analysis for Contraceptives by End-Use - Household, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Mexico Historic Review for Contraceptives by End-Use - Household, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Mexico 15-Year Perspective for Contraceptives by End-Use - Percentage Breakdown of Value Sales for Household, Hospitals and Clinics for the Years 2012, 2020 & 2027 |
| REST OF LATIN AMERICA |
| Rest of Latin America Current & Future Analysis for Contraceptives by Product Type - Drugs and Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Latin America Historic Review for Contraceptives by Product Type - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Latin America 15-Year Perspective for Contraceptives by Product Type - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2012, 2020 & 2027 |
| Rest of Latin America Current & Future Analysis for Contraceptives by Gender - Female and Male - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Latin America Historic Review for Contraceptives by Gender - Female and Male Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Latin America 15-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female and Male for the Years 2012, 2020 & 2027 |
| Rest of Latin America Current & Future Analysis for Contraceptives by End-Use - Household, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Latin America Historic Review for Contraceptives by End-Use - Household, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Latin America 15-Year Perspective for Contraceptives by End-Use - Percentage Breakdown of Value Sales for Household, Hospitals and Clinics for the Years 2012, 2020 & 2027 |
| MIDDLE EAST |
| Middle East Current & Future Analysis for Contraceptives by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| Middle East Historic Review for Contraceptives by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Middle East 15-Year Perspective for Contraceptives by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2020 & 2027 |
| Middle East Current & Future Analysis for Contraceptives by Product Type - Drugs and Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Middle East Historic Review for Contraceptives by Product Type - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Middle East 15-Year Perspective for Contraceptives by Product Type - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2012, 2020 & 2027 |
| Middle East Current & Future Analysis for Contraceptives by Gender - Female and Male - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Middle East Historic Review for Contraceptives by Gender - Female and Male Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Middle East 15-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female and Male for the Years 2012, 2020 & 2027 |
| Middle East Current & Future Analysis for Contraceptives by End-Use - Household, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Middle East Historic Review for Contraceptives by End-Use - Household, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Middle East 15-Year Perspective for Contraceptives by End-Use - Percentage Breakdown of Value Sales for Household, Hospitals and Clinics for the Years 2012, 2020 & 2027 |
| IRAN |
| Iran Current & Future Analysis for Contraceptives by Product Type - Drugs and Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Iran Historic Review for Contraceptives by Product Type - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Iran 15-Year Perspective for Contraceptives by Product Type - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2012, 2020 & 2027 |
| Iran Current & Future Analysis for Contraceptives by Gender - Female and Male - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Iran Historic Review for Contraceptives by Gender - Female and Male Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Iran 15-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female and Male for the Years 2012, 2020 & 2027 |
| Iran Current & Future Analysis for Contraceptives by End-Use - Household, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Iran Historic Review for Contraceptives by End-Use - Household, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Iran 15-Year Perspective for Contraceptives by End-Use - Percentage Breakdown of Value Sales for Household, Hospitals and Clinics for the Years 2012, 2020 & 2027 |
| ISRAEL |
| Israel Current & Future Analysis for Contraceptives by Product Type - Drugs and Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Israel Historic Review for Contraceptives by Product Type - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Israel 15-Year Perspective for Contraceptives by Product Type - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2012, 2020 & 2027 |
| Israel Current & Future Analysis for Contraceptives by Gender - Female and Male - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Israel Historic Review for Contraceptives by Gender - Female and Male Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Israel 15-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female and Male for the Years 2012, 2020 & 2027 |
| Israel Current & Future Analysis for Contraceptives by End-Use - Household, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Israel Historic Review for Contraceptives by End-Use - Household, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Israel 15-Year Perspective for Contraceptives by End-Use - Percentage Breakdown of Value Sales for Household, Hospitals and Clinics for the Years 2012, 2020 & 2027 |
| SAUDI ARABIA |
| Saudi Arabia Current & Future Analysis for Contraceptives by Product Type - Drugs and Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Saudi Arabia Historic Review for Contraceptives by Product Type - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Saudi Arabia 15-Year Perspective for Contraceptives by Product Type - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2012, 2020 & 2027 |
| Saudi Arabia Current & Future Analysis for Contraceptives by Gender - Female and Male - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Saudi Arabia Historic Review for Contraceptives by Gender - Female and Male Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Saudi Arabia 15-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female and Male for the Years 2012, 2020 & 2027 |
| Saudi Arabia Current & Future Analysis for Contraceptives by End-Use - Household, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Saudi Arabia Historic Review for Contraceptives by End-Use - Household, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Saudi Arabia 15-Year Perspective for Contraceptives by End-Use - Percentage Breakdown of Value Sales for Household, Hospitals and Clinics for the Years 2012, 2020 & 2027 |
| UNITED ARAB EMIRATES |
| UAE Current & Future Analysis for Contraceptives by Product Type - Drugs and Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UAE Historic Review for Contraceptives by Product Type - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| UAE 15-Year Perspective for Contraceptives by Product Type - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2012, 2020 & 2027 |
| UAE Current & Future Analysis for Contraceptives by Gender - Female and Male - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UAE Historic Review for Contraceptives by Gender - Female and Male Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| UAE 15-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female and Male for the Years 2012, 2020 & 2027 |
| UAE Current & Future Analysis for Contraceptives by End-Use - Household, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UAE Historic Review for Contraceptives by End-Use - Household, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| UAE 15-Year Perspective for Contraceptives by End-Use - Percentage Breakdown of Value Sales for Household, Hospitals and Clinics for the Years 2012, 2020 & 2027 |
| REST OF MIDDLE EAST |
| Rest of Middle East Current & Future Analysis for Contraceptives by Product Type - Drugs and Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Middle East Historic Review for Contraceptives by Product Type - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Middle East 15-Year Perspective for Contraceptives by Product Type - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2012, 2020 & 2027 |
| Rest of Middle East Current & Future Analysis for Contraceptives by Gender - Female and Male - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Middle East Historic Review for Contraceptives by Gender - Female and Male Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Middle East 15-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female and Male for the Years 2012, 2020 & 2027 |
| Rest of Middle East Current & Future Analysis for Contraceptives by End-Use - Household, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Middle East Historic Review for Contraceptives by End-Use - Household, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Middle East 15-Year Perspective for Contraceptives by End-Use - Percentage Breakdown of Value Sales for Household, Hospitals and Clinics for the Years 2012, 2020 & 2027 |
| AFRICA |
| Africa Current & Future Analysis for Contraceptives by Product Type - Drugs and Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Africa Historic Review for Contraceptives by Product Type - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Africa 15-Year Perspective for Contraceptives by Product Type - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2012, 2020 & 2027 |
| Africa Current & Future Analysis for Contraceptives by Gender - Female and Male - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Africa Historic Review for Contraceptives by Gender - Female and Male Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Africa 15-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female and Male for the Years 2012, 2020 & 2027 |
| Africa Current & Future Analysis for Contraceptives by End-Use - Household, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Africa Historic Review for Contraceptives by End-Use - Household, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Africa 15-Year Perspective for Contraceptives by End-Use - Percentage Breakdown of Value Sales for Household, Hospitals and Clinics for the Years 2012, 2020 & 2027 |
| IV. COMPETITION |
| Total Companies Profiled: 92 |
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com